The utility of serum lipids as a marker of hepatic steatosis and fibrosis in patients with chronic HCV infection.

被引：0
|
作者：
Garcia, N
Levy, JR
Lippman, RH
Winzenried, G
Gilles, HS
Abou-Assi, SG
Pandak, W
Schubert, ML
Heuman, DM
Mihas, AA
机构：
来源：
GASTROENTEROLOGY | 2002年 / 123卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [41] Correlation of hepatic steatosis with body mass index, serum ferritin level and hepatic fibrosis in Japanese patients with chronic hepatitis C
    Sumida, Yoshio
    Kanemasa, Kazuyuki
    Fukumoto, Kohei
    Yoshida, Naohisa
    Sakai, Kyoko
    HEPATOLOGY RESEARCH, 2007, 37 (04) : 263 - 269
  • [42] FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
    Vallet-Pichard, Adays
    Mallet, Vincent
    Nalpas, Bertrand
    Verkarre, Virginie
    Nalpas, Antoine
    Dhalluin-Venier, Valerie
    Fontaine, Helene
    Pol, Stanislas
    HEPATOLOGY, 2007, 46 (01) : 32 - 36
  • [43] The clinical significance of intrahepatic hepatitis C virus (HCV) levels in patients with chronic HCV infection.
    Haydon, GH
    Jarvis, LM
    Hayes, PC
    Harrison, DJ
    HEPATOLOGY, 1996, 24 (04) : 1041 - 1041
  • [44] Concentration of LDLR, degree of hepatic fibrosis and hepatic steatosis in patients with chronic hepatitis B infection treated with tenofovir disoproxil fumarate
    Pokora-Rodak, Agnieszka
    Krzowska-Firych, Joanna
    Tomasiewicz, Krzysztof
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2021, 28 (03) : 458 - 462
  • [45] Platelet count as an indirect marker of histological severity in chronic hepatitis C virus (HCV) infection.
    Figueiredo-Mendes, CG
    Al Mattos, C
    Figueiredo, VM
    Pacheco, MS
    Perez, RM
    Silva, AE
    Ferraz, ML
    HEPATOLOGY, 2000, 32 (04) : 550A - 550A
  • [46] Cytokine serum levels in patients with chronic HCV infection
    Spanakis, NE
    Garinis, GA
    Alexopoulos, EC
    Patrinos, GP
    Menounos, PG
    Sklavounou, A
    Manolis, EN
    Gorgoulis, VG
    Valis, D
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2002, 16 (01) : 40 - 46
  • [47] Assessment of noninvasive hepatic fibrosis markers among patients with chronic HCV infection and advanced liver disease
    Maan, Raoel
    van der Meer, Adriaan J.
    Feld, Jordan J.
    Wedemeyer, Heiner
    DuFour, Jean-Francois J.
    Lammert, Frank
    Duarte-Rojo, Andres
    Manns, Michael P.
    Zeuzem, Stefan
    Hofmann, Wolf P.
    Janssen, Harry L.
    Hansen, Bettina E.
    Veldt, Bart J.
    de Knegt, Robert J.
    HEPATOLOGY, 2014, 60 : 929A - 930A
  • [48] Inluence of HLA class II DR alleles on hepatic fibrosis in 271 patients with chronic HCV infection
    Halfon, P
    Renou, C
    Cacoub, P
    Hue, S
    Thibaut, V
    Charlotte, F
    Piette, JC
    Picon, M
    Rifflet, H
    Bertrand, JJ
    Pol, S
    Caillat, S
    GASTROENTEROLOGY, 1999, 116 (04) : A1218 - A1218
  • [49] Detection of a common deletion in the mitochondrial DNA of patients with chronic hepatitis C virus (HCV) infection and hepatic steatosis.
    Alan, B
    Droogan, O
    Nolan, N
    Farrell, MA
    Hegarty, JE
    HEPATOLOGY, 2000, 32 (04) : 226A - 226A
  • [50] The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis
    Magri, Mariana Cavalheiro
    Manchiero, Caroline
    Gago Prata, Thamiris Vaz
    da Silva Nunes, Arielle Karen
    de Oliveira Junior, Jose Santos
    Dantas, Bianca Peixoto
    Tengan, Fatima Mitiko
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 97 (02)
12345